Valuation (12%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -10.59 | -22.08 |
| PEG Ratio (TTM) | -0.86 | 15.66 |
| P/S Ratio (TTM) | 9.94 | 49.38 |
| P/B Ratio (TTM) | 4.49 | 18.85 |
| P/FCF Ratio (TTM) | -14.65 | -3.07 |
| Price to 5YR AVG Earnings Ratio | -7.40 | -3.42 |
| Price to 5YR AVG FCF Ratio | -10.02 | -9.04 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -30.22% | -5.15% |
| ROE (TTM) | -37.96% | 16.37% |
| Net Profit Margin (TTM) | -92.45% | -2,030.32% |
| ROIC 5YR AVG | -132.72% | 15.65% |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -0.01% | -52.30% | -18.64% |
| Revenue | 10.83% | 3,467.45% | 2,095.08% |
| Net Income | -0.34% | -75.56% | -33.14% |
| Cash Flow | -93.00% | -87.72% | -36.80% |
Health (53%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.46 | 6.19 |
| Quick Ratio (TTM) | 3.29 | 5.91 |
| D/E Ratio (TTM) | 0.12 | -15.10 |
| Interest Coverage (TTM) | -16.87 | -1.60 |
| Piotroski F-Score | 3 | 5 |
| Altman Z-Score | 3.69 | 14.02 |
| LTL to 5YR AVG FCF | -0.03 | 0.18 |
| Shares Outstanding Growth 5YR AVG | 15.80% | 123.85% |